Medicines for malaria, tuberculosis, and AIDS are all available for children, but none are formulated specifically for the younger patient population. Recently, the World Health Organization generated an essential drug list for kids. How will they follow up on this effort? Dr. Stephen M. Spielberg, professor of pediatrics, pharmacology and toxicology at Dartmouth Medical School, and principal investigator for the Institute for Pediatric Innovation's Pediatric Pharmaceutical Reformulation Project, joins host Dr. Bill Rutenberg to discuss some of the challenges ahead: formulation, dosing, preservation, delivery and beyond.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Worldwide Challenge: Formulating Drugs for Children
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Recommended
Details
Presenters
Comments
Recommended
Overview
Medicines for malaria, tuberculosis, and AIDS are all available for children, but none are formulated specifically for the younger patient population. Recently, the World Health Organization generated an essential drug list for kids. How will they follow up on this effort? Dr. Stephen M. Spielberg, professor of pediatrics, pharmacology and toxicology at Dartmouth Medical School, and principal investigator for the Institute for Pediatric Innovation's Pediatric Pharmaceutical Reformulation Project, joins host Dr. Bill Rutenberg to discuss some of the challenges ahead: formulation, dosing, preservation, delivery and beyond.
Presenters
Facebook Comments